"Even in this time of uncertainty, Mayo Clinic is a place for hope and healing — and we're delivering the care you need. Mayo Clinic follows carefully designed, rigorously enforced safety precautions for anyone who needs face-to-face care. We're safely treating all patients, both in person and through virtual visits, in adherence with federal and state executive orders and guidance. Mayo Clinic’s teams diagnose and treat more than 500 neurological conditions, including many rare or complex disorders, for thousands of patients each year. Mayo Clinic uses state-of-the-art diagnostic and treatment facilities, as well as numerous groundbreaking clinical trials."

During the past decade, Mayo Clinic, Department of Neurology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mayo Clinic, Department of Neurology" #1 sponsor was "Chelsea Therapeutics" with 2 trials, followed by "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "National Eye Institute (NEI)" with 1 trials sponsored, "National Institute of Environmental Health Sciences (NIEHS)" with 1 trials sponsored and "TauRx Therapeutics Ltd" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mayo Clinic, Department of Neurology" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic, Department of Neurology" are "Biliary Tract Cancer" (2 trials), "Cholangiocarcinoma" (2 trials), "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Gallbladder Cancer" (2 trials) and "Behavioral Variant Frontotemporal Dementia (bvFTD)" (1 trials). Many other conditions were trialed in "Mayo Clinic, Department of Neurology" in a lesser frequency.

Most popular intervention types in "Mayo Clinic, Department of Neurology" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Droxidopa" (2 trials), "M7824" (2 trials), "Cisplatin" (1 trials) and "Civamide (Zucapsaicin)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic, Department of Neurology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Mayo Clinic, Department of Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Mayo Clinic, Department of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic, Department of Neurology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".